Aktuellt
SENASTE
Redeye embraces yet another record quarter from BONESUPPORT, continuing to support our thesis and financial projections for the coming years. We slightly up our sales estimates for 2022E, and certain cost estimates though non-affecting our fair value range.
LÄS MER
